Abstract
Introduction: De-novo malignancy (DNM) has become an important cause of death after long term survival following liver transplantation (LT). We share our experience of identifying and managing post-transplant patients with DNM and analysis of possible risk factors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: HPB : the official journal of the International Hepato Pancreato Biliary Association
Paper Title
Journal
Date
